Abstract 6650: Safety and efficacy of belzutifan for Von Hippel-Lindau disease-associated tumors.

Authors

Mohamed G. Atta (ORCID: https://orcid.org/0000-0001-7572-9961)
Nityasree Srialluri
Peixi Ge

Institutions

Johns Hopkins University (US)
Johns Hopkins Medicine (US)
University of Baltimore (US)

Publication Details

Journal: Cancer Research
Published: 2026-04-03
DOI: https://doi.org/10.1158/1538-7445.am2026-6650
Primary Topic: Cancer, Hypoxia, and Metabolism
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Abstract 6650: Safety and efficacy of belzutifan for Von Hippel-Lindau disease-associated tumors.

Mohamed G. Atta, Nityasree Srialluri, Peixi Ge

Apr 3, 2026

Cancer Research

Cancer, Hypoxia, and Metabolism

article

Abstract 6650: Safety and efficacy of belzutifan for Von Hippel-Lindau disease-associated tumors.

Mohamed G. Atta, Nityasree Srialluri, Peixi Ge

April 3, 2026article en

Abstract

No abstract available for this paper.

Cancer ResearchVol. 86(7_Supplement)

Johns Hopkins University (US), Johns Hopkins Medicine (US), University of Baltimore (US)

Good health and well-being

Openalex Percentile: Top 7%

Cancer, Hypoxia, and Metabolism

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Abstract 6650: Safety and efficacy of belzutifan for Von Hippel-Lindau disease-associated tumors. — Mohamed G. Atta, Nityasree Srialluri, et al. · Cancer Research (2026) | TGRS Research Map | TGRS